Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Psychological Reports|April 14, 2005
Preliminary study of psychological factors affecting clinic attendance and glycemic control of Japanese patients with type 2 diabetes mellitusMikayo Ando, Shinichiro Ando, Toshiaki TakeuchiAmbio|April 28, 2016
Generating an agricultural risk map based on limited ecological information: A case study using Sicyos angulatusTakeshi Osawa, Shigenori Okawa, Shunji Kurokawa, et al.Health Education & Behavior : the Official Publication of the Society for Public Health Education|January 4, 2007
A psychoeducational program to prevent aggressive behavior among Japanese early adolescentsMikayo Ando, Takashi Asakura, Shinichiro Ando, et al.Biopsychosocial Medicine|July 6, 2007
Psychosocial factors associated with smoking and drinking among Japanese early adolescent boys and girls: cross-sectional studyMikayo Ando, Takashi Asakura, Shinichiro Ando, et al.Internal Medicine (Tokyo, Japan)|June 12, 2020
Severe Visceral Obesity, Fatty Liver and Diabetes after Orchiectomy for Prostate CancerNobuo Kajitani, Junko Takahashi, Hiroyuki Honda, et al.Molecular and Cellular Endocrinology|January 31, 2006
Thyroid hormone action at the cellular, genomic and target gene levelsPaul M Yen, Shinichiro Ando, Xu Feng, et al.Molecular Endocrinology (Baltimore, Md.)|December 31, 2004
p62, A TFIIH subunit, directly interacts with thyroid hormone receptor and enhances T3-mediated transcriptionYing Liu, Shinichiro Ando, Xianmin Xia, et al.Frontiers in Cardiovascular Medicine|June 10, 2021
Novel Urinary Glycan Biomarkers Predict Cardiovascular Events in Patients With Type 2 Diabetes: A Multicenter Prospective Study With 5-Year Follow Up (U-CARE Study 2)Koki Mise, Mariko Imamura, Satoshi Yamaguchi, et al.BMJ Open Diabetes Research & Care|May 30, 2024
Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3)Asami Ueno, Yasuhiro Onishi, Koki Mise, et al.Diabetes, Obesity & Metabolism|May 2, 2022
Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE studySatoshi Miyamoto, Hiddo J L Heerspink, Dick de Zeeuw, et al.Pageof 2